Company: IOBT
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047744
Chunk: 111

Company: IO Biotech, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 111
---
 provided by financing activities

    —

    71,860

    Net decrease in cash, cash equivalents and restricted cash

    (82,391
    )

    (200
    )

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (771
    )

    803

    Cash, cash equivalents and restricted cash, beginning of year

    143,461

    142,858

    Cash, cash equivalents and restricted cash, end of year
     
    $
    60,299

    $
    143,461

    Components of cash, cash equivalents, and restricted cash

    Cash and cash equivalents

    60,031

    143,193

    Restricted cash

    268

    268

          Total cash, cash equivalents, and restricted cash
     
    $
    60,299

    $
    143,461

See accompanying notes to the consolidated financial statements. 

146

io biotech, inc.